Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

AE6C: AZT prodrug with improved toxicity profile

May 24, 1996

So324: Stavudine prodrug with potent anti-HIV activity

May 24, 1996

New allophenylnorstatine protease inhibitors from Japan Energy

May 24, 1996

HIV fusin described in Science by NIAID researchers

May 17, 1996

UNAIDS initiates clinical program to evaluate Advantage 24 in STD transmission

May 17, 1996

FDA okays second Cell Genesys AIDS gene therapy trial

May 17, 1996

Toho University reports anti-HIV zinc complex dimers

May 17, 1996

HMR reports anti-HIV guanine derivative

May 17, 1996

GEM-132 IND filing imminent

May 10, 1996

ALX40-4C blocks HIV infection

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...